AnandRathi

Novelix Pharmaceuticals Ltd Fundamental Analysis

Last Updated Date: 21 Sept 2026
77.50
-0.76 (-0.97%)

Novelix Pharmaceuticals Ltd (Novelix Pharma.) fundamental analysis breaks down the key financial metrics of the small-cap Pharmaceuticals company, which carries a market capitalisation of ₹221 crore.

Novelix Pharmaceuticals Ltd Overview

Market cap₹221 Crs
Volume4,230
Prev. Close₹78.26
Year range₹38.00 - ₹92.00
ISININE314I01036

Novelix Pharmaceuticals Ltd Fundamentals

ROCE(TTM)6.70%
P/E Ratio (TTM)61.02
P/B Ratio3.36
Debt to Equity0.09
ROE5.50%
EPS (TTM)1.27
Dividend Yield0.00%
Book Value23.08
Profit Margin2.46%
Operating Margin3.02%

Novelix Pharmaceuticals Ltd Historical Performance

1 Month Return-1.07%
6 Month Return44.32%
3 Year Return670.38%
3 Month Return-2.65%
1 Year Return93.80%
5 Year Return1105.29%

Novelix Pharmaceuticals Ltd Share Price History

High:0.00
Low:0.00
No History Available

Disclaimer

The information provided on this page is for informational purposes only and should not be construed as investment advice, recommendation, or solicitation to buy or sell any securities or financial pr...

Frequently Asked Questions

Download TradeMobi App

  • Real-Time Market Data
  • Advanced Trading Tools
  • Expert-Backed Research